Description:ML281, with the CAS number 1404437-62-2, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its role as a selective inhibitor of the enzyme protein kinase C (PKC). This compound is characterized by its ability to modulate various cellular processes, including cell proliferation and differentiation, making it a subject of interest in cancer research and other therapeutic areas. ML281 exhibits a specific binding affinity for certain PKC isoforms, which can lead to distinct biological effects depending on the cellular context. Its chemical structure typically includes functional groups that contribute to its pharmacological properties, enhancing its selectivity and potency. Additionally, ML281's solubility, stability, and metabolic profile are important factors that influence its potential as a drug candidate. Ongoing studies aim to further elucidate its mechanism of action and therapeutic applications, highlighting its significance in the development of targeted therapies.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
![2-Thiophenecarboxamide, N-[2-(3,4-dihydro-3-oxo-2-quinoxalinyl)-4-(1-methylethyl)phenyl]-](https://static.cymitquimica.com/products/IN/thumb/DA001CG0.jpg)
